Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biotis Co., Ltd. is a South Korean biotechnology company specializing in the development and manufacture of advanced bioactive materials for tissue engineering and regenerative medicine. Founded in 2001 and headquartered in Daejeon, the company focuses on providing innovative solutions for bone and soft tissue repair, particularly in the dental and orthopedic sectors. Its product portfolio includes synthetic bone graft substitutes, xenografts, and dental membranes designed to facilitate natural bone growth and structural integration. Biotis leverages its expertise in calcium phosphate ceramics and biocompatible polymers to serve a global market, while also conducting research into growth factor delivery systems to enhance healing outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biotis.